Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated
guidelines for the definition and interpretation of cell death from morphological, biochemical, …

We have identified two cell types, each using almost exclusively one of two different CD95 (APO-1/Fas)
signaling pathways. In type I cells, caspase-8 was activated within seconds and …

Apoptosis or programmed cell death is a key regulator of physiological growth control and
regulation of tissue homeostasis. One of the most important advances in cancer research in …

To characterize cell surface molecules involved in control of growth of malignant lymphocytes,
monoclonal antibodies were raised against the human B lymphoblast cell line SKW6.4. …

THE APO-l/(Fas/CD95) cell surface receptor is a member of the nerve growth factor (NGF)/tumour
necrosis factor (TNF) receptor superfamily and mediates apoptosis 1 –4 . Peripheral …

Cytotoxic drugs used in chemotherapy of leukemias and solid tumors cause apoptosis in
target cells 1,2 . In lymphoid cells the CD95 (APO–1/Fas)/CD95 ligand (CD95–L) system is a …

A major concern in cancer therapy is resistance of tumors such as glioblastoma to current
treatment protocols. Here, we report that transfer of the gene encoding second mitochondria-…

Anticancer treatment using cytotoxic drugs is considered to mediate cell death by activating
key elements of the apoptosis program and the cellular stress response. While proteolytic …

Apoptosis, the cell's intrinsic death program, is a key regulator of tissue homeostasis. An
imbalance between cell death and proliferation may result in tumor formation. Also, killing of …

Activation of apoptosis pathways is a key mechanism by which cytotoxic drugs kill tumor cells.
Also immunotherapy of tumors requires an apoptosis sensitive phenotype of target cells. …